Cargando…
Nano‐delivery systems as a promising therapeutic potential for epilepsy: Current status and future perspectives
Epilepsy is a common chronic neurological disorder caused by aberrant neuronal electrical activity. Antiseizure medications (ASMs) are the first line of treatment for people with epilepsy (PWE). However, their effectiveness may be limited by their inability to cross the blood–brain barrier (BBB), am...
Autores principales: | Movahedpour, Ahmad, Taghvaeefar, Rasul, Asadi‐Pooya, Ali‐Akbar, Karami, Yousof, Tavasolian, Ronia, Khatami, Seyyed Hossein, Soltani Fard, Elahe, Taghvimi, Sina, Karami, Neda, Rahimi Jaberi, Khojaste, Taheri‐Anganeh, Mortaza, Ghasemi, Hassan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580365/ https://www.ncbi.nlm.nih.gov/pubmed/37452477 http://dx.doi.org/10.1111/cns.14355 |
Ejemplares similares
-
Exosomes: Promising Delivery Tools for Overcoming Blood-Brain Barrier and Glioblastoma Therapy
por: Khatami, Seyyed Hossein, et al.
Publicado: (2023) -
In silico Evaluation of PLAC1-fliC As a Chimeric Vaccine against Breast Cancer
por: Taheri-Anganeh, Mortaza, et al.
Publicado: (2020) -
LytU-SH3b fusion protein as a novel and efficient enzybiotic against methicillin-resistant Staphylococcus aureus
por: Taheri-Anganeh, Mortaza, et al.
Publicado: (2019) -
In silico analysis of suitable signal peptides for secretion of a recombinant alcohol dehydrogenase with a key role in atorvastatin enzymatic synthesis
por: Taheri-Anganeh, Mortaza, et al.
Publicado: (2019) -
LYZ2-SH3b as a novel and efficient enzybiotic against methicillin-resistant Staphylococcus aureus
por: Asadi, Marzieh, et al.
Publicado: (2023)